全文获取类型
收费全文 | 2972篇 |
免费 | 274篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 74篇 |
妇产科学 | 52篇 |
基础医学 | 344篇 |
口腔科学 | 59篇 |
临床医学 | 372篇 |
内科学 | 716篇 |
皮肤病学 | 40篇 |
神经病学 | 225篇 |
特种医学 | 91篇 |
外科学 | 448篇 |
综合类 | 56篇 |
预防医学 | 269篇 |
眼科学 | 99篇 |
药学 | 180篇 |
中国医学 | 2篇 |
肿瘤学 | 208篇 |
出版年
2022年 | 21篇 |
2021年 | 38篇 |
2020年 | 26篇 |
2019年 | 50篇 |
2018年 | 57篇 |
2017年 | 46篇 |
2016年 | 35篇 |
2015年 | 45篇 |
2014年 | 78篇 |
2013年 | 106篇 |
2012年 | 146篇 |
2011年 | 131篇 |
2010年 | 97篇 |
2009年 | 67篇 |
2008年 | 138篇 |
2007年 | 138篇 |
2006年 | 141篇 |
2005年 | 155篇 |
2004年 | 148篇 |
2003年 | 169篇 |
2002年 | 134篇 |
2001年 | 87篇 |
2000年 | 84篇 |
1999年 | 73篇 |
1998年 | 46篇 |
1997年 | 34篇 |
1996年 | 29篇 |
1995年 | 31篇 |
1993年 | 27篇 |
1992年 | 67篇 |
1991年 | 50篇 |
1990年 | 40篇 |
1989年 | 37篇 |
1988年 | 35篇 |
1987年 | 39篇 |
1986年 | 38篇 |
1985年 | 51篇 |
1984年 | 35篇 |
1983年 | 34篇 |
1982年 | 26篇 |
1981年 | 34篇 |
1979年 | 23篇 |
1978年 | 27篇 |
1977年 | 35篇 |
1976年 | 28篇 |
1975年 | 28篇 |
1974年 | 29篇 |
1973年 | 30篇 |
1972年 | 25篇 |
1970年 | 22篇 |
排序方式: 共有3258条查询结果,搜索用时 15 毫秒
1.
2.
3.
Eduardo Rodrigues‐Pinto Joel Ferreira‐Silva Guilherme Macedo Douglas K. Rex 《Digestive endoscopy》2019,31(5):583-587
Cecal intubation is a critical aspect of effective, complete colonoscopy. Difficult colonoscopy is most often considered as one in which it is challenging or impossible to reach the cecum. It may be a common occurrence due to patient and/or endoscopist factors. Incomplete colonoscopies should be avoided, since patients in this context present an important prevalence of lesions that escape examination. The approach to successful cecal intubation should depend on characterization of the problem as redundant colon or difficult sigmoid colon. Most patients with a prior incomplete colonoscopy can be colonoscoped successfully, if careful attention is paid to technique, using a variety of scopes, colonoscopy methods and additional equipment. Sufficient time should be allotted to make the attempt. 相似文献
4.
5.
6.
Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases 总被引:2,自引:0,他引:2
G Smith R A Elton G D Chisholm J E Newsam T B Hargreave 《British journal of urology》1986,58(6):659-663
Of 299 patients who presented with superficial bladder cancer (Ta, T1), 60 were treated by intravesical chemotherapy (Epodyl, methotrexate or mitomycin C). The rate of tumour progression to muscle invasion or metastases was identical for each intravesical regime. There was no evidence that mitomycin C promoted tumour progression. Carcinoma in situ in non-tumour-bearing urothelium was the most significant predictive factor for progression to muscle invasion or metastases. 相似文献
7.
The mechanism of action of systemitically administered(±)-MDMA (3, 4-methylenedioxymethamphetamine) on spontaneously active neurons in the medial prefrontal cortex (mPFc) of chloral hydrate anesthetized rats was examined using standard single unit extracellular recording techniques. Intravenously administered MDMA dose-dependently decreased the firing rates of the majority of mPFc neurons in control rats. In contrast, in rats that were pretreated withp-chlorophenylalanine (PCPA), which depletes the brain serotonin (5-hydroxytryptamine, 5-HT) content by inhibiting tryptophan hydroxylase, the rate-limiting enzyme in the synthesis of 5-HT, MDMA was largely ineffective in inhibiting the firing of mPFc cells. In PCPA-treated animals, the administration of 5-hydroxytryptophan (5-HTP), which presumably restored the brain 5-HT content, but notl-DOPA, reinstated MDMA's inhibitory action in PCPA-treated rats. In rats that were pretreated withα-methyl-p-tyrosine (AMPT), which depletes the brain dopamine (DA) content by inhibiting tyrosine hydroxylase, the rate-limiting enzyme in the synthesis of DA, MDMA inhibited the firing of all of the mPFc cells. MDMA's effect on mPFc neurons was reversed by 5-HT receptor antagonists such as granisetron and metergoline. These results strongly suggest that MDMA exerts its action on mPFc cells indirectly by releasing endogenous 5-HT. 相似文献
8.
Dr. Rex O. Brown Pharm.D. Dr. Roland N. Dickerson Pharm.D. Dr. Emily B. Hak Pharm.D. Dr. J. Barret Matthews M.D. Dr. Lawrence J. Hak Pharm.D. 《Pharmacotherapy》1997,17(4):796-800
A pharmacist consult service was developed to evaluate the appropriateness of enteral feeding through a permanent ostomy in 24 nonambulatory patients with severe developmental disabilities. Several problems with enteral nutrition were identified. Policies to improve them were instituted, and several educational presentations were made. Pharmacists' actions were implemented, including assessment of energy needs by indirect calorimetry and rearrangement of enteral feeding schedules to achieve optimal nutrition support and pharmacotherapy administration. By the fourth month of the consult service, body weight in these patients increased from 101 ± 6% of baseline to 109 ± 7% (p<0.05). Weight continued to increase through the seventh month of the consult service to 116 ± 12% of baseline (p<0.0001). Measured resting energy expenditure for the group was 889 ± 170 kcal/day compared with the predicted 1055 ± 163 kcal/day. 相似文献
9.
Charles R. Ashby Yoshio Minabe Alon Toor Lyle D. Fishkin Martin I. Granoff Rex Y. Wang 《Drug development research》1994,31(3):228-236
This study examined the effect of acute and chronic administration of the selective 5-HT3 receptor antagonist BRL 46470A, an analog of granisetron, on the number of spontaneously active dopamine (DA) cells in the substantia nigra pars compacta (A9 or SNC) and the ventral tegmental area (A10 or VTA) in the rat. In the A10 area, the acute administration of BRL 46470A decreased the number of spontaneously active DA cells at a dose of 0.1 mg/kg (0.28 μmol/kg) ip, yet increased the number of spontaneously active DA cells at a dose of 0.3 mg/kg (0.84 μmol/kg). The chronic administration (21 days) of BRL 46470A appeared to produce a multiphasic dose-response curve. Thus, the chronic treatment with BRL 46470A increased the number of spontaneously active A10 DA cells at 0.03 (0.084 μmol) and 0.3 mg/kg, but decreased the number of spontaneously active A10 DA cells at a dose of 0.1 mg/kg. In contrast, BRL 46470A did not decrease the number of spontaneously active A9 DA cells after either acute or chronic administration (0.01-0.3 mg/kg). However, BRL 46470A did increase the number of spontaneously active A9 DA cells at acute and chronic doses similar to those that were effective in A10. The iv administration of (+)-apomorphine (APO) not only failed to reverse the decrease produced by chronic administration of BRL 46470A at 0.1 mg/kg, but further decreased the number of spontaneously active A10 DA cells. Similar to the results obtained with granisetron, the pretreatment of naive rats with either 0.01 or 0.1 mg/kg iv of BRL 46470A significantly potentiated (2-fold) the suppressant action of APO on the basal firing rate of A10, but not A9 DA cells. Overall, our results indicate that similar to granisetron, chronic BRL 46470A at 0.1 mg/kg selectively decreases the number of spontaneously active A10 DA cells, via a mechanism not related to depolarization inactivation. Presently, it is not clear what factors may contribute to the multiphasic dose-response curve of BRL 46470A. © 1994 Wiley-Liss, Inc. 相似文献
10.